Right Ventricular Pacing With Mechanical Dyssynchrony Causes Apoptosis Interruptus and Calcium Mishandling

Canadian Journal of Cardiology

Volumn 29, Issue 4, 2013, Pages 510-518

  Klug, Didier ^a,b   Boule, Stephane ^b   Wissocque, Ludivine ^b   Montaigne, David ^a,b   Marechal, Xavier ^a   Hassoun, Sidi Mohamed ^a   Neviere, Remi ^a  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; INHIBITOR OF APOPTOSIS PROTEIN; PHOSPHOLAMBAN; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CELL SURVIVAL; ENDOCARDIAL BIPOLAR SCREW; FEMALE; HEART ATRIUM PACING; HEART FUNCTION; HEART LEFT VENTRICLE; HEART PACING; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FAILURE; IMPLANTATION; JUGULAR VEIN; MECHANICAL DYSSYNCHRONY; MEDICAL DEVICE; NONHUMAN; PACEMAKER; PROTEIN EXPRESSION; RIGHT VENTRICULAR PACING; SODIUM CALCIUM EXCHANGE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; CASPASES; CELL SURVIVAL; ECHOCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HEART RATE; HEART VENTRICLES; MYOCYTES, CARDIAC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875578966     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.08.007     Document Type: Article

References (32)

1. Barth A.S., Aiba T., Halperin V., et al. Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circ Cardiovasc Genet 2009, 2:371-378.
2. Gao Z., Barth A.S., DiSilvestre D., et al. Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling. Physiol Genomics 2008, 35:222-230.
3. Ojaimi C., Qanud K., Hintze T.H., Recchia F.A. Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. Physiol Genomics 2007, 29:76-83.
4. Aiba T., Tomaselli G.F. Electrical remodeling in the failing heart. Curr Opin Cardiol 2010, 25:29-36.
5. Barth A.S., Chakir K., Kass D.A., Tomaselli G.F. Transcriptome, proteome, and metabolome in dyssynchronous heart failure and CRT. J Cardiovasc Transl Res 2012, 5:180-187.
6. Lionetti V., Aquaro G.D., Simioniuc A., et al. Severe mechanical dyssynchrony causes regional hibernation-like changes in pigs with nonischemic heart failure. J Card Fail 2009, 15:920-928.
7. Marin-Garcia J., Goldenthal M.J., Damle S., Pi Y., Moe G.W. Regional distribution of mitochondrial dysfunction and apoptotic remodeling in pacing-induced heart failure. J Card Fail 2009, 15:700-708.
8. Spragg D.D., Akar F.G., Helm R.H., Tunin R.S., Tomaselli G.F., Kass D.A. Abnormal conduction and repolarization in late-activated myocardium of dyssynchronously contracting hearts. Cardiovasc Res 2005, 67:77-86.
9. Aiba T., Hesketh G.G., Barth A.S., et al. Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation 2009, 119:1220-1230.
10. Chakir K., Daya S.K., Tunin R.S., et al. Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation 2008, 117:1369-1377.
11. Spragg D.D., Leclercq C., Loghmani M., et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 2003, 108:929-932.
12. Cesselli D., Jakoniuk I., Barlucchi L., et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 2001, 89:279-286.
13. Leri A., Liu Y., Malhotra A., et al. Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation 1998, 97:194-203.
14. Prescimone T., Lionetti V., Caselli C., et al. Severity of regional myocardial dysfunction is not affected by cardiomyocyte apoptosis in non-ischemic heart failure. Pharmacol Res 2011, 63:207-215.
15. Abbate A., Narula J. Role of apoptosis in adverse ventricular remodeling. Heart Fail Clin 2012, 8:79-86.
16. Narula J., Haider N., Arbustini E., Chandrashekhar Y. Mechanisms of disease: apoptosis in heart failure-seeing hope in death. Nat Clin Pract Cardiovasc Med 2006, 3:681-688.
17. Lancel S., Joulin O., Favory R., et al. Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation 2005, 111:2596-2604.
18. Neviere R., Hassoun S.M., Decoster B., et al. Caspase-dependent protein phosphatase 2A activation contributes to endotoxin-induced cardiomyocyte contractile dysfunction. Crit Care Med 2010, 38:2031-2036.
19. Communal C., Sumandea M., de Tombe P., Narula J., Solaro R.J., Hajjar R.J. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci USA 2002, 99:6252-6256.
20. Laugwitz K.L., Moretti A., Weig H.J., et al. Blocking caspase-activated apoptosis improves contractility in failing myocardium. Hum Gene Ther 2001, 12:2051-2063.
21. Moretti A., Weig H.J., Ott T., et al. Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc Natl Acad Sci USA 2002, 99:11860-11865.
22. Schwab B.L., Guerini D., Didszun C., et al. Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis. Cell Death Differ 2002, 9:818-831.
23. Paszty K., Antalffy G., Hegedus L., et al. Cleavage of the plasma membrane Ca+ATPase during apoptosis. Ann N Y Acad Sci 2007, 1099:440-450.
24. Regula K.M., Kirshenbaum L.A. Apoptosis of ventricular myocytes: a means to an end. J Mol Cell Cardiol 2005, 38:3-13.
25. Piacentino V., Milano C.A., Bolanos M., et al. X-Linked Inhibitor of apoptosis protein-mediated attenuation of apoptosis, using a novel cardiac-enhanced adeno-associated viral vector. Hum Gene Ther 2012, 23:635-646.
26. Kim S.J., Kuklov A., Crystal G.J. In vivo gene delivery of XIAP protects against myocardial apoptosis and infarction following ischemia/reperfusion in conscious rabbits. Life Sci 2011, 88:572-577.
27. Haider N., Arbustini E., Gupta S., et al. Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts. Nat Clin Pract Cardiovasc Med 2009, 6:250-261.
28. Patten R.D., Hall-Porter M.R. Small animal models of heart failure: development of novel therapies, past and present. Circ Heart Fail 2009, 2:138-144.
29. Dixon J.A., Spinale F.G. Large animal models of heart failure: a critical link in the translation of basic science to clinical practice. Circ Heart Fail 2009, 2:262-271.
30. Paslawska U., Gajek J., Kiczak L., et al. Development of porcine model of chronic tachycardia-induced cardiomyopathy. Int J Cardiol 2011, 153:36-41.
31. O'Rourke B., Kass D.A., Tomaselli G.F., Kaab S., Tunin R., Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. Circ Res 1999, 84:562-570.
32. Perreault C.L., Shannon R.P., Komamura K., Vatner S.F., Morgan J.P. Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure. J Clin Invest 1992, 89:932-938.